Log in to save to my catalogue
Log in to save to my catalogue

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhi...

| Ask | Become a Library member

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_2610630

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

About this item

Full title

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

Author / Creator

Wamil, Barbara D. , Thurman, Gary B. , Sundell, Hakan W. , DeVore, Russell F. , Wakefield, Gail , Johnson, David H. , Wang, Yue-Fen and Hellerqvist, C. G.

Publisher

Berlin: Springer

Journal title

Journal of cancer research and clinical oncology, 1997-03, Vol.123 (3), p.173-179

Language

English

Formats

Articles

Publication information

Publisher

Berlin: Springer

Subjects

More information

Alternative Titles

Full title

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pascalfrancis_primary_2610630

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_2610630

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s004320050046

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections